Zebrafish Patient-Derived Avatars from Digestive Cancers for Anti-cancer Therapy Screening.
CRC
avatars
chemotherapy screening
digestive cancers
personalized medicine
zebrafish xenografts
Journal
Current protocols
ISSN: 2691-1299
Titre abrégé: Curr Protoc
Pays: United States
ID NLM: 101773894
Informations de publication
Date de publication:
Apr 2022
Apr 2022
Historique:
entrez:
18
4
2022
pubmed:
19
4
2022
medline:
21
4
2022
Statut:
ppublish
Résumé
Patient-derived xenografts (PDXs), also called "avatars," are generated by the implantation of human primary tumor cells or tissues into a host animal. Given the complexity and unique characteristics of each tumor, PDXs are models of choice in cancer research and precision medicine. In this context, the zebrafish PDX model (zPDX or zAvatar) has been recognized as a promising in vivo model to directly challenge patient cells with anti-cancer therapies in a personalized manner. The assay relies on the injection of tumor cells from patients into zebrafish embryos to then test and identify the best available drug combination for a particular patient. Compared to mouse PDXs, zAvatar assays take less time and do not require in vitro or in vivo cell expansion. The present article describes how to generate zAvatars from resected digestive cancer from surgeries and how to then use them for anti-cancer therapy screening. We describe the steps for tumor sample collection and cryopreservation, sample preparation and fluorescent labeling for microinjection into zebrafish embryos, drug administration, and analysis of tumor behavior by single-cell confocal imaging. We provide detailed protocols and helpful tips for performing this assay, and we address the technical challenges associated with the workflow. © 2022 Wiley Periodicals LLC. Basic Protocol 1: Patient tumor sample collection and cryopreservation Basic Protocol 2: Generation of zAvatars and anti-cancer treatment Basic Protocol 3: Whole-mount immunofluorescence Basic Protocol 4: Confocal imaging and analysis.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e415Informations de copyright
© 2022 Wiley Periodicals LLC.
Références
Bentley, V. L., Veinotte, C. J., Corkery, D. P., Pinder, J. B., LeBlanc, M. A., Bedard, K., … Dellaire, G. (2015). Focused chemical genomics using zebrafish xenotransplantation as a pre-clinical therapeutic platform for T-cell acute lymphoblastic leukemia. Haematologica, 100(1), 70-76. doi: 10.3324/haematol.2014.110742.
Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., & Jemal, A. (2018). Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians, 68(6), 394-424. doi: 10.3322/caac.21492.
Cabezas-Sáinz, P., Pensado-López, A., Sáinz, B. Jr., & Sánchez, L. (2020). Modeling cancer using zebrafish xenografts: Drawbacks for mimicking the human microenvironment. Cells, 9(9), 1978. doi: 10.3390/cells9091978.
Chen, X., Wang, J., Cao, Z., Hosaka, K., Jensen, L., Yang, H., … Cao, Y. (2015). Invasiveness and metastasis of retinoblastoma in an orthotopic zebrafish tumor model. Scientific Reports, 5(1), 10351. doi: 10.1038/srep10351.
Chiu, Y-C., Chen, H-I. H., Zhang, T., Zhang, S., Gorthi, A., Wang, L-J., & Chen, Y. (2019). Predicting drug response of tumors from integrated genomic profiles by deep neural networks. BMC Medical Genomics, 12(1), 18. doi: 10.1186/s12920-018-0460-9.
Cornet, C., Dyballa, S., Terriente, J., & Di Giacomo, V. (2019). ZeOncoTest: Refining and automating the zebrafish xenograft model for drug discovery in cancer. Pharmaceuticals (Basel), 13(1), 1. doi: 10.3390/ph13010001.
Costa, B., Estrada, M. F., Mendes, R. V., & Fior, R. (2020). Zebrafish avatars towards personalized medicine-a comparative review between avatar models. Cells, 9(2), 293. doi: 10.3390/cells9020293.
Costa, B., Ferreira, S., Póvoa, V., Cardoso, M. J., Vieira, S., Stroom, J., … Fior, R. (2020). Developments in zebrafish avatars as radiotherapy sensitivity reporters - towards personalized medicine. eBioMedicine, 51, 102578. doi: 10.1016/j.ebiom.2019.11.039.
Date, S., & Sato, T. (2015). Mini-gut organoids: Reconstitution of the stem cell niche. Annual Review of Cell and Developmental Biology, 31, 269-289. doi: 10.1146/annurev-cellbio-100814-125218.
Di Franco, G., Usai, A., Funel, N., Palmeri, M., Montesanti, I. E. R., Bianchini, M., … Morelli, L. (2020). Use of zebrafish embryos as avatar of patients with pancreatic cancer: A new xenotransplantation model towards personalized medicine. World Journal of Gastroenterology, 26(21), 2792-2809. doi: 10.3748/wjg.v26.i21.2792.
Driehuis, E., Gracanin, A., Vries, R. G. J., Clevers, H., & Boj, S. F. (2020). Establishment of pancreatic organoids from normal tissue and tumors. STAR Protocols, 1(3), 100192. doi: 10.1016/j.xpro.2020.100192.
Driehuis, E., van Hoeck, A., Moore, K., Kolders, S., Francies, H. E., Gulersonmez, M. C., … Clevers, H. (2019). Pancreatic cancer organoids recapitulate disease and allow personalized drug screening. Proceedings of the National Academy of Sciences, 116(52), 26580-26590. doi: 10.1073/pnas.1911273116.
Ducreux, M., Cuhna, A. S., Caramella, C., Hollebecque, A., Burtin, P., & Goéré, D., … ESMO Guidelines Committee (2015). Cancer of the pancreas: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Annals of Oncology, 26(Suppl 5), v56-v68. doi: 10.1073/pnas.1911273116.
Durinikova, E., Buzo, K., & Arena, S. (2021). Preclinical models as patients' avatars for precision medicine in colorectal cancer: Past and future challenges. Journal of Experimental & Clinical Cancer Research, 40(1), 185. doi: 10.1186/s13046-021-01981-z.
Fazio, M., Ablain, J., Chuan, Y., Langenau, D. M., & Zon, L. I. (2020). Zebrafish patient avatars in cancer biology and precision cancer therapy. Nature Reviews Cancer, 20(5), 263-273. doi: 10.1038/s41568-020-0252-3.
Fior, R., Póvoa, V., Mendes, R. V., Carvalho, T., Gomes, A., Figueiredo, N., … Ferreira, M. G. (2017). Single-cell functional and chemosensitive profiling of combinatorial colorectal therapy in zebrafish xenografts. Proceedings of the National Academy of Sciences, 114(39), E8234-E43. doi: 10.1073/pnas.1618389114.
Haldi, M., Ton, C., Seng, W. L., & McGrath, P. (2006). Human melanoma cells transplanted into zebrafish proliferate, migrate, produce melanin, form masses and stimulate angiogenesis in zebrafish. Angiogenesis, 9(3), 139-151. doi: 10.1007/s10456-006-9040-2.
He, S., Lamers, G. E., Beenakker, J. W., Cui, C., Ghotra, V. P., Danen, E. H., … Snaar-Jagalska, B. E. (2012). Neutrophil-mediated experimental metastasis is enhanced by VEGFR inhibition in a zebrafish xenograft model. The Journal of Pathology, 227(4), 431-445. doi: 10.1002/path.4013.
Hidalgo, M., Amant, F., Biankin, A. V., Budinská, E., Byrne, A. T., Caldas, C., … Villanueva, A. (2014). Patient-derived xenograft models: An emerging platform for translational cancer research. Cancer Discovery, 4(9), 998-1013. doi: 10.1158/2159-8290.CD-14-0001.
Izumchenko, E., Paz, K., Ciznadija, D., Sloma, I., Katz, A., Vasquez-Dunddel, D., … Sidransky, D. (2017). Patient-derived xenografts effectively capture responses to oncology therapy in a heterogeneous cohort of patients with solid tumors. Annals of Oncology, 28(10), 2595-2605. doi: 10.1093/annonc/mdx416.
Kimmel, C. B., Ballard, W. W., Kimmel, S. R., Ullmann, B., & Schilling, T. F. (1995). Stages of embryonic development of the zebrafish. Developmental Dynamics, 203(3), 253-310. doi: 10.1002/aja.1002030302.
Lam, S. H., Chua, H. L., Gong, Z., Lam, T. J., & Sin, Y. M. (2004). Development and maturation of the immune system in zebrafish, Danio rerio: A gene expression profiling, in situ hybridization and immunological study. Developmental and Comparative Immunology, 28(1), 9-28. doi: 10.1016/s0145-305x(03)00103-4.
Lam, S. H., Wu, Y. L., Vega, V. B., Miller, L. D., Spitsbergen, J., Tong, Y., … Gong, Z. (2006). Conservation of gene expression signatures between zebrafish and human liver tumors and tumor progression. Nature Biotechnology, 24(1), 73-75. doi: 10.1038/nbt1169.
Lee, J-K., Liu, Z., Sa, J. K., Shin, S., Wang, J., Bordyuh, M., … Nam, D.-H. (2018). Pharmacogenomic landscape of patient-derived tumor cells informs precision oncology therapy. Nature Genetics, 50(10), 1399-1411. doi: 10.1038/s41588-018-0209-6.
Lee, S. L. C., Rouhi, P., Jensen, L. D., Zhang, D., Ji, H., Hauptmann, G., … Cao, Y. (2009). Hypoxia-induced pathological angiogenesis mediates tumor cell dissemination, invasion, and metastasis in a zebrafish tumor model. Proceedings of the National Academy of Sciences, 106(46), 19485. doi: 10.1073/pnas.0909228106.
Letrado, P., de Miguel, I., Lamberto, I., Díez-Martínez, R., & Oyarzabal, J. (2018). Zebrafish: Speeding up the cancer drug discovery process. Cancer Research, 78(21), 6048-6058. doi: 10.1158/0008-5472.CAN-18-1029.
Lin, J., Zhang, W., Zhao, J. J., Kwart, A. H., Yang, C., Ma, D., … Munshi, N. C. (2016). A clinically relevant in vivo zebrafish model of human multiple myeloma to study preclinical therapeutic efficacy. Blood, 128(2), 249-252. doi: 10.1182/blood-2016-03-704460.
Malaney, P., Nicosia, S. V., & Davé, V. (2014). One mouse, one patient paradigm: New avatars of personalized cancer therapy. Cancer Letters, 344(1), 1-12. doi: 10.1016/j.canlet.2013.10.010.
Martinez-Lopez, M., Póvoa, V., & Fior, R. (2021). Generation of zebrafish larval xenografts and tumor behavior analysis. JoVE, (172), e62373. doi: 10.3791/62373.
Marques, I. J., Weiss, F. U., Vlecken, D. H., Nitsche, C., Bakkers, J., Lagendijk, A. K., … Bagowski, C. P. (2009). Metastatic behaviour of primary human tumours in a zebrafish xenotransplantation model. BMC Cancer, 9(1), 128. doi: 10.1186/1471-2407-9-128.
Matchett, K. B., Lynam-Lennon, N., Watson, R. W., & Brown, J. A. L. (2017). Advances in precision medicine: Tailoring individualized therapies. Cancers (Basel), 9(11), 146. doi: 10.1186/1471-2407-9-128.
Mercatali, L., La Manna, F., Groenewoud, A., Casadei, R., Recine, F., Miserocchi, G., … Snaar-Jagalska, E. (2016). Development of a patient-derived xenograft (PDX) of breast cancer bone metastasis in a zebrafish model. International Journal of Molecular Sciences, 17(8), 1375. doi: 10.3390/ijms17081375.
Nicoli, S., Ribatti, D., Cotelli, F., & Presta, M. (2007). Mammalian tumor xenografts induce neovascularization in zebrafish embryos. Cancer Research, 67(7), 2927. doi: 10.1158/0008-5472.CAN-06-4268.
Pleguezuelos-Manzano, C., Puschhof, J., van den Brink, S., Geurts, V., Beumer, J., & Clevers, H. (2020). Establishment and culture of human intestinal organoids derived from adult stem cells. Current Protocols in Immunology, 130(1), e106. doi: 10.1002/cpim.106.
Pompili, L., Porru, M., Caruso, C., Biroccio, A., & Leonetti, C. (2016). Patient-derived xenografts: A relevant preclinical model for drug development. Journal of Experimental & Clinical Cancer Research, 35(1), 189. doi: 10.1186/s13046-016-0462-4.
Póvoa, V., Rebelo de Almeida, C., Maia-Gil, M., Sobral, D., Domingues, M., Martinez-Lopez, M., … Fior, R. (2021). Innate immune evasion revealed in a colorectal zebrafish xenograft model. Nature Communications, 12(1), 1156. doi: 10.1038/s41467-021-21421-y.
Rebelo de Almeida, C., Mendes, R. V., Pezzarossa, A., Gago, J., Carvalho, C., Alves, A., … Fior, R. (2020). Zebrafish xenografts as a fast screening platform for bevacizumab cancer therapy. Communications Biology, 3(1), 299. doi: 10.1038/s42003-020-1015-0.
Renshaw, S. A., & Trede, N. S. (2012). A model 450 million years in the making: Zebrafish and vertebrate immunity. Disease Models & Mechanisms, 5(1), 38-47. doi: 10.1242/dmm.007138.
Richter, M., Piwocka, O., Musielak, M., Piotrowski, I., Suchorska, W. M., & Trzeciak, T. (2021). From donor to the lab: A fascinating journey of primary cell lines. Frontiers in Cell and Developmental Biology, 9, 711381. doi: 10.3389/fcell.2021.711381.
Sant, K. E., & Timme-Laragy, A. R. (2018). Zebrafish as a model for toxicological perturbation of yolk and nutrition in the early embryo. Current Environmental Health Reports, 5(1), 125-133. doi: 10.1007/s40572-018-0183-2.
Sato, T., & Clevers, H. (2013). Growing self-organizing mini-guts from a single intestinal stem cell: Mechanism and applications. Science, 340(6137), 1190-1194. doi: 10.1126/science.1234852.
Sato, T., Stange, D. E., Ferrante, M., Vries, R. G., Van Es, J. H., Van den Brink, S., … Clevers, H. (2011). Long-term expansion of epithelial organoids from human colon, adenoma, adenocarcinoma, and Barrett's epithelium. Gastroenterology, 141(5), 1762-1772. doi: 10.1053/j.gastro.2011.07.050.
Schindelin, J., Arganda-Carreras, I., Frise, E., Kaynig, V., Longair, M., Pietzsch, T., … Cardona, A. (2012). Fiji: An open-source platform for biological-image analysis. Nature Methods, 9(7), 676-682. doi: 10.1038/nmeth.2019.
Smyth, E. C., Verheij, M., Allum, W., Cunningham, D., Cervantes, A., & Arnold, D. (2016). Gastric cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Annals of Oncology, 27, v38-v49. doi: 10.1093/annonc/mdw350.
Stoletov, K., Kato, H., Zardouzian, E., Kelber, J., Yang, J., Shattil, S., & Klemke, R. (2010). Visualizing extravasation dynamics of metastatic tumor cells. Journal of Cell Science, 123(Pt 13), 2332-2341. doi: 10.1242/jcs.069443.
Tavares Barroso, M., Costa, B., Rebelo de Almeida, C., Castillo Martin, M., Couto, N., Carvalho, T., … Fior, R. (2021). Establishment of pancreatobiliary cancer zebrafish avatars for chemotherapy screening. Cells, 10(8), 2077. doi: 10.3390/cells10082077.
Taylor, A. M., & Zon, L. I. (2009). Zebrafish tumor assays: The state of transplantation. Zebrafish, 6(4), 339-346. doi: 10.1089/zeb.2009.0607.
Van Cutsem, E., Cervantes, A., Adam, R., Sobrero, A., Van Krieken, J. H., Aderka, D., … Arnold, D. (2016). ESMO consensus guidelines for the management of patients with metastatic colorectal cancer. Annals of Oncology, 27(8), 1386-1422. doi: 10.1093/annonc/mdw235.
Varanda, A. B., Martins-Logrado, A., Godinho Ferreira, M., & Fior, R. (2020). Zebrafish xenografts unveil sensitivity to olaparib beyond BRCA status. Cancers (Basel), 12(7), 1769. doi: 10.3390/cancers12071769.
Vlachogiannis, G., Hedayat, S., Vatsiou, A., Jamin, Y., Fernández-Mateos, J., Khan, K., … Valeri, N. (2018). Patient-derived organoids model treatment response of metastatic gastrointestinal cancers. Science, 359(6378), 920-926. doi: 10.1126/science.aao2774.
Williams, J. A. (2018). Using PDX for preclinical cancer drug discovery: The evolving field. Journal of Clinical Medicine, 7(3), 41. doi: 10.3390/jcm7030041.
Wu, J-Q., Zhai, J., Li, C-Y., Tan, A-M., Wei, P., Shen, L-Z., & He, M-F. (2017). Patient-derived xenograft in zebrafish embryos: A new platform for translational research in gastric cancer. Journal of Experimental & Clinical Cancer Research, 36(1), 160. doi: 10.1186/s13046-017-0631-0.
Yang, H., Sun, L., Liu, M., & Mao, Y. (2018). Patient-derived organoids: A promising model for personalized cancer treatment. Gastroenterology Report, 6(4), 243-245. doi: 10.1093/gastro/goy040.
Yui, S., Nakamura, T., Sato, T., Nemoto, Y., Mizutani, T., Zheng, X., … Watanabe, M. (2012). Functional engraftment of colon epithelium expanded in vitro from a single adult Lgr5+ stem cell. Nature Medicine, 18(4), 618-623. doi: 10.1038/nm.2695.
Zhao, C., Wang, X., Zhao, Y., Li, Z., Lin, S., Wei, Y., … Yong, H. (2011). A novel xenograft model in zebrafish for high-resolution investigating dynamics of neovascularization in tumors. PLOS ONE, 6(7), e21768. doi: 10.1371/journal.pone.0021768.